AR007616A1 - Combinaciones antivirales - Google Patents
Combinaciones antiviralesInfo
- Publication number
- AR007616A1 AR007616A1 ARP970102758A ARP970102758A AR007616A1 AR 007616 A1 AR007616 A1 AR 007616A1 AR P970102758 A ARP970102758 A AR P970102758A AR P970102758 A ARP970102758 A AR P970102758A AR 007616 A1 AR007616 A1 AR 007616A1
- Authority
- AR
- Argentina
- Prior art keywords
- amino
- combinations
- oxathiolan
- pyrimidin
- hydroxymethyl
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 208000031886 HIV Infections Diseases 0.000 abstract 2
- JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 abstract 2
- 239000002777 nucleoside Substances 0.000 abstract 2
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 2
- HBOMLICNUCNMMY-UHFFFAOYSA-N 1-[4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1OC(CO)C(N=[N+]=[N-])C1 HBOMLICNUCNMMY-UHFFFAOYSA-N 0.000 abstract 1
- XQSPYNMVSIKCOC-NTSWFWBYSA-N Emtricitabine Chemical compound C1=C(F)C(N)=NC(=O)N1[C@H]1O[C@@H](CO)SC1 XQSPYNMVSIKCOC-NTSWFWBYSA-N 0.000 abstract 1
- 230000036436 anti-hiv Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- -1 tetrahydro-3-furanyl ester Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 abstract 1
- 229960002555 zidovudine Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se relaciona con las combinaciones terapéuticas del ácido 3S-[3R(1R, 2S)]-[3-[[(4-aminofenil)sulfonil](2-metilpropil)-amino]--2-hidroxi-1-fenil-metil)propil]carbámico, tetrahidro-3-furanil éster (141W94),3-azido-3-desoxitimid ina (zidovudina) y (2R, cis)-4-amino-1-(2-hidroximetil-- 1,3-oxatiolan-5-il)-(1H)-pirimidin-2-ona (3TC) (o, de manera alternativa a 3TC, (2R, cis)-4-amino-5-flúor-1-(2-hidroximetil-1,3-oxatiolan-5-il)--pirimidin-2-ona (FTC),las cuales tienen acti vidad anti-VIH. La presente invención también se relaciona con las composiciones farmacéuticas quecontienen tales combinaciones y su uso en el tratamiento de las infecciones con VIH incluyendo las infecciones conmutantes del VIH que tienen res istencia alos inhibidores nucleosídicos y/o no nucleosídicos.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2054396P | 1996-06-25 | 1996-06-25 | |
| US2102796P | 1996-07-02 | 1996-07-02 | |
| GBGB9614022.3A GB9614022D0 (en) | 1996-07-04 | 1996-07-04 | Antiviral therapeutic combinations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR007616A1 true AR007616A1 (es) | 1999-11-10 |
Family
ID=10796331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970102758A AR007616A1 (es) | 1996-06-25 | 1997-06-23 | Combinaciones antivirales |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR007616A1 (es) |
| GB (1) | GB9614022D0 (es) |
| PE (1) | PE87298A1 (es) |
-
1996
- 1996-07-04 GB GBGB9614022.3A patent/GB9614022D0/en active Pending
-
1997
- 1997-06-23 PE PE00053497A patent/PE87298A1/es not_active Application Discontinuation
- 1997-06-23 AR ARP970102758A patent/AR007616A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GB9614022D0 (en) | 1996-09-04 |
| PE87298A1 (es) | 1999-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199700203A1 (ru) | Синергические комбинации зидовудина, 1592u89 и 3тс или ftc | |
| YU58398A (en) | Combinations comprising vx478, zidovudine, ftc and/or 3tc for use the terapy of hiv | |
| TW366347B (en) | Antiviral pharmaceutical compositions comprising 1,3-oxathiolane nucleoside analogues | |
| NO20053817L (no) | Preparater og fremgangsmater for antiviral kombinasjonsterapi. | |
| RU94013464A (ru) | Нуклеозидные аналоги 1,3-оксатиолана, способ получения, фармацевтическая композиция, способ лечения вирусной инфекции | |
| CA3156667A1 (en) | Oligonucleotides with nucleoside analogs | |
| UY24930A1 (es) | Composiciones farmaceuticas que contienen (2r, cis)-4-amino-1-(2-hidroximetil-1,3 -oxatiolan-5-il)-(1h)-pirimidin-2-ona (lamivudina) | |
| AR007616A1 (es) | Combinaciones antivirales | |
| YU58498A (en) | Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv | |
| GT199900083A (es) | Combinaciones terapeuticas para la fragilidad musculoesqueletica. | |
| AR040242A1 (es) | Composiciones farmaceuticas | |
| AR007615A1 (es) | Combinaciones antivirales, formulaciones conteniendo las mismas, uso de los mismos en la manufactura de medicamentos y un articulo que los contiene. | |
| NO995620L (no) | Antivirale kombinasjoner inneholdende karbocyklisk nukleosid 1592U89 | |
| TH34798A (th) | การรวมสารต้านไวรัส | |
| AR040805A1 (es) | Composiciones que contienen tenofovir y emtricitabina y metodos para terapia antiviral | |
| WO2000018383A3 (en) | Antiviral combinations comprising (s)-2- ethyl-7- fluoro-3- oxo-3,4- dihydro-2h- quinoxaline-1- carboxylic acid isopropyl ester | |
| UY25926A1 (es) | Formulaciones farmaceuticas de ester tetrahidro-3-furanilico del acido 3s-(3r*(1r*,2s*))-(3-(((4-aminofenil)sulfonil)(2-metilpropil)-amino)-2-hidroxi-1-fenilmetil)propil carbamico | |
| ECSP982450A (es) | Composiciones farmaceuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |